There is accumulating evidence suggesting that the drug Trasylol, manufactured by Bayer AG and used to prevent excessive bleeding during heart bypass surgery, increases the risk of death when compared with other drugs, according to the United States Food and Drug Administration (FDA).
Discuss Add this link to... Tell a friendBury Add to:
| Bookmarks
Comments